Search results
Results from the WOW.Com Content Network
Prolactin, a major hormone of the HPP axis.. The hypothalamic–pituitary–prolactin axis (HPP axis), also known as the hypothalamic–pituitary–mammary axis or hypothalamic–pituitary–breast axis, is a hypothalamic–pituitary axis which includes the secretion of prolactin (PRL; luteotropin) from the lactotrophs of the pituitary gland into the circulation and the subsequent action of ...
Necropsy later revealed an acidophilic adenoma with immunohistochemical staining for growth hormone, adrenocorticotropic hormone, and prolactin. [6] In 2007 a 10 year old male Dalmatian dog was described with acromegalic signs such as an enlarged tongue and head, widened interdental space, and thickening of skin; along with other signs of ...
It is secreted heavily in pulses in between these events. Prolactin plays an essential role in metabolism, regulation of the immune system and pancreatic development. [6] [7] Discovered in non-human animals around 1930 by Oscar Riddle [8] and confirmed in humans in 1970 by Henry Friesen, [9] prolactin is a peptide hormone, encoded by the PRL ...
These hormones are prolactin, growth hormone, TSH, adrenocorticotropic hormone, FSH and LH. They are all released by anterior pituitary. Some have targets in glands and some with direct function. Anterior pituitary is an amalgam of hormone producing glandular cells. There are conditions related to the limbic system which regulate the hormone ...
Worms and other internal parasites can be treated easily but are some of the most common problems seen in dogs. Some of the internal parasites that cause diarrhea and loose stools in puppies ...
Releasing hormones and inhibiting hormones are hormones whose main purpose is to control the release of other hormones, either by stimulating or inhibiting their release. They are also called liberins ( / ˈ l ɪ b ə r ɪ n z / ) and statins ( / ˈ s t æ t ɪ n z / ) (respectively), or releasing factors and inhibiting factors .
Hypoprolactinemia can result from autoimmune disease, [2] hypopituitarism, [1] growth hormone deficiency, [2] hypothyroidism, [2] excessive dopamine action in the tuberoinfundibular pathway and/or the anterior pituitary, and ingestion of drugs that activate the D 2 receptor, such as direct D 2 receptor agonists like bromocriptine and pergolide, and indirect D 2 receptor activators like ...
The hypothalamic–pituitary–somatotropic axis (HPS axis), or hypothalamic–pituitary–somatic axis, also known as the hypothalamic–pituitary–growth axis, is a hypothalamic–pituitary axis which includes the secretion of growth hormone (GH; somatotropin) from the somatotropes of the pituitary gland into the circulation and the subsequent stimulation of insulin-like growth factor 1 ...